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I had hoped that this capture recapture report would give a reliable estimate of the prevalence  
of opiate use in Ireland in 2006. However, due to a number of technical factors, relating to the 
population of the survey not being “closed” and to the diminishing overlap between the 3 sources 
used, this has not proved possible using the capture recapture methodology. The result is an 
overestimate of the opiate using population. 
The general consensus is that, while heroin use has been relatively stable in the Dublin area over 
the last number of years, its use has become more widely dispersed around the country. The use of 
heroin continues to be concentrated primarily in areas of urban disadvantage in Dublin and in other 
urban centres, particularly in Leinster and the south of the country. Among the factors that have led 
to this conclusion is the experience of service providers, the fact that the rate of new entrants to 
treatment had dropped significantly (by approximately 20% between 2001/02 and 2006/07) and  
the average age of those in treatment had increased from 28 to 33 in the same period. 
I am satisfied that the advances in treatment provision since 2006, combined with the 
implementation of the National Drugs Strategy 2009-16, will address the needs of those presenting 
for treatment for opiate use in the coming months and years. I am working currently with the 
Health Services Executive and other service providers to ensure that this happens. 
Irrespective of the unreliability of the outcome, which relates solely to the use of the capture-
recapture methodology in the current Irish context, I would like to record my appreciation of  
the work of Dr. Alan Kelly and his team, as well as the NACD, in producing this report. 
John Curran T.D.
Minister for Drugs 
Foreword – Minister of State
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The provision of timely and comparable data on the prevalence of drug misuse in Ireland is a core function 
of the NACD. Through this work the NACD also contributes to the collation of data on the key indicators 
of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Obtaining a reliable view 
of the extent of illicit drug use in the population, however, can be difficult because opiate users in 
particular are largely a hidden population due to the illegal nature of their activity. For this reason, 
it is necessary to establish an estimate that will provide us with an approximate picture of drug use. 
One of the key methodologies favoured by the EMCDDA for estimating the number of opiate users is the 
capture recapture method. This report, which updates a similar national study for the years 2000-2001, 
uses the capture recapture method in order to estimate the extent of opiate use in Ireland for 2006. 
Notwithstanding the fact that the methodology used is that suggested by the EMCDDA and that the 
researchers have conducted a rigorous high-quality scientific evaluation of the data, the NACD 
believes that the overall estimate in this report must be treated with a considerable degree of 
caution. The expansion of places on the methadone treatment programme between 2001 and 2006, 
which in itself is positive, has led to technical complications in the estimation of the hidden opiate 
user population via capture recapture methods. For the reasons given in the report, the figures for 
Dublin are considered likely to be inflated. The inflation in the estimate for the rest of Ireland is 
thought to be proportionally larger. Unfortunately, the NACD is not in a position to determine the 
extent of the inflation of the estimate. In light of these issues, the NACD proposes to undertake 
research during 2010 into other methods of estimating the prevalence of drug use. 
While it is difficult to assess the overall extent of opiate drug use for 2006 because of the issues with 
the capture recapture method, some key findings are worth noting. For example, the percentage of 
young male opiate users in treatment outside Dublin (31% males 15-24 years) is consistently lower 
than that for Dublin (55%). This may reflect the more recent spread of opiate use outside Dublin and 
the ensuing but more recent development of methadone treatment services outside Dublin. The NACD 
recommends continued investment in existing opiate treatment services and calls for expansion of 
opiate treatment services outside of Dublin as a matter of urgency. The NACD also reiterates its strong 
endorsement of the recommendations of the Working Group on Drugs Rehabilitation for an expansion 
of the range of treatment options for recovering drug users, an increase in the number of residential 
detoxification beds and an increase in the number and geographical spread of residential and 
community detoxification places provided by the non-statutory, voluntary, and community sectors. 
Finally, on behalf of the NACD, I would like to thank Dr. Alan Kelly and his colleagues Marlene 
Carvalho and Conor Teljeur for their excellent report and for their perseverance in bringing what was 
a particularly challenging study to a conclusion. Their report reminds us that opiate use is a chronic 
problem and that the population of users is ageing. This highlights an emerging issue as such older 
drug users are likely to have increasing levels of health problems. The report also shows how 
services for opiate users have evolved and expanded over the period 2001 to 2006, but at the same 
time illustrates the gaps in services that still exist, particularly outside of Dublin. 
I would also like to thank my colleagues on the Prevalence Sub-Committee for their intensive input 
into the preparation of this report. In particular, Dr Jean Long has brought her considerable energy 
and expertise to bear during our detailed consideration of the findings and I would like to record my 
appreciation of her efforts.
As ever our thanks are also due to the staff of the NACD for their hard work during the preparation of 
the report for publication.
Dr Des Corrigan FPSI
Chairperson 
NACD
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Foreword – Chairperson NACD
We would like to thank Assistant Garda Commissioner Donnellan and Superintendent Barry O’Brien 
for their cooperation in providing the necessary data from the Garda Study on Drugs, Crime and 
Related Criminal Activity. We also wish to acknowledge the assistance of Prof. Joe Barry in obtaining 
data from the Central Drug Treatment List. To the CEOs of the hospitals we contacted to obtain 
access to their HIPE records we extend our appreciation and also to the many members of the 
various Hospital Ethics Committees for their understanding of the study requirements and without 
whose approval the HIPE data could not have been released.
Finally, our thanks to the members of the NACD Sub-Committee on Prevalence, who provided advice 
and encouragement as the study progressed, in particular, to Dr Jean Long for her considerable input 
to the text of the final document.
Acknowledgements
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This study estimates the prevalence of problem opiate use in Ireland in 2006 using a 3-source 
capture-recapture method. The three population sources employed to calculate the estimate were 
the Central (methadone) Treatment List (CTL), the Hospital In-Patient Enquiry Scheme (HIPE) and the 
Garda list of opiate users.
Table 1 provides a summary of the findings of this study. It presents the estimated prevalence of 
opiate use as numbers of individuals (males & females combined), and the corresponding rates per 
1,000 population, for the year 2006 for:
i) Ireland;
ii) Dublin; and
iii) the rest of Ireland excluding Dublin.
Table 1: Number of opiate users known, estimated number hidden, prevalence estimate and population rate in Dublin 
and in the Rest of Ireland, 2006
Region
Age
Group
Known
Number
Estimated 
Hidden Number
Estimated
Prevalence
(95% CIs)
Rate/1,000
population
Ireland 15-64 11,807* 8,983 20,790 
(18,136 – 23,576)
7.2
Dublin 15-64 9,442 5,462 14,904 
(13,737 – 16,450)
17.6
Rest of Ireland 15-64 2,365 3,521 5,886 
(4,399 – 7,126)
2.9
* This number is the sum of the unique numbers for Dublin and the Rest of Ireland and, as such, it excludes 116 
individuals of no fixed abode, the vast majority of whom were in treatment.
The 3-source Capture Recapture estimates indicate that 11,807 opiate users aged 15-64 years were 
known to services in Ireland in 2006 and an estimated 8,983 users were not known to the services 
(hidden population). The estimate suggests that there were between 18,136 and 23,576 problem 
opiate users in Ireland in 2006; the point estimate was 20,790.
The estimates are likely to be inflated because the population was not closed, that is, it continued to 
recruit significant numbers of people into treatment (in Dublin and outside Dublin) and police custody 
(outside Dublin) in 2006. In addition, because of the large numbers on the Central (methadone) 
Treatment List, the overlap between the three population sources was small. These two factors are 
known to inflate estimates obtained through the capture-recapture method
Twenty eight per cent (5,886) of the estimated number resided outside Dublin and 72% (14,904) 
resided in Dublin. The respective population rates for Dublin and the Rest of Ireland are 17.6 per 
1,000 and 2.9 per 1,000.
Seventy one per cent of the estimated number of opiate users was male. One in five (21%) was 
between 15 and 24 years old and half (51%) were between 25 and 34 years old.
7
Summary
8The point estimate for Ireland has increased by 42%, from 14,681 in 2001 to 20,790 in 2006.  
The point estimate for Dublin increased by 20% while the point estimate for the rest of Ireland 
(excluding Dublin) increased by 165%; of note, the estimate of opiate users living outside Dublin  
was relatively small in 2001.
In Dublin, the rate of opiate use per 1,000 of the 15-24 year old female population decreased by 62%, 
from 18.7 in 2001 to 7.2 in 2006 and this indicates that the number of younger women commencing 
opiate use has decreased. A lower (32%) but considerable decrease in the rate of opiate use was also 
noted for men aged 15-24 years.
The rate of opiate use per 1,000 of the 15-64 year old population residing outside Dublin increased 
from 1.2 in 2001 to 2.9 in 2006 and this indicates that opiate use has increased outside Dublin.
In an unpublished study, Kelly and colleagues report that retaining opiate users in treatment reduces 
their likelihood of being in contact with the Gardaí (Dr A. Kelly, personal communication, 2009). For 
example, only 12% of males aged 25-34 years who were attending treatment services between 2001 
and 2006 and known to the Gardaí in 2001 continued committing crime in 2006. This is in line with 
findings from the ROSIE Study1 (Prof CM Comiskey et al, 2009) and indicates that methadone 
treatment reduces the incidence of crime.
The detailed results of the study are presented in the main body of this report.
1 Comiskey, C.M., Kelly, P., Leckey, Y., McCullough, L., O’Dhuill, B., Stapleton, R.D., White, E. (2009) The Rosie Study: Drug Treatment 
Outcomes in Ireland. National Advisory Committee on Drugs, Stationery Office, Dublin.
9This is a report of the findings of a national 3-source capture-recapture study to estimate the number 
of problem opiate users in the Irish population for the year 2006. The capture-recapture methodology 
is the principal indirect method for estimating the prevalence of a partially hidden population such 
as opiate users. Given the nature of this population, a simple head-count is not feasible, as some 
opiate users have no contact with any service provider – hence the need to rely  
on a statistical model based on what we do know about this population.
While originally developed to determine the numbers in various wildlife populations, for example,  
a given bird species, this method has gained in popularity as a useful tool to provide statistical 
estimates in epidemiological studies. It has been extensively used in population-based opiate 
prevalence studies, both abroad and in Ireland, and is a recommended method of the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in Lisbon.
The study was commissioned by the National Advisory Committee on Drugs (NACD) following an 
open tendering process. The study updates a similar national study for the years 2000 and 2001.2
In order to calculate prevalence, the numbers are expressed as a rate per 1,000 of the 15-64 year 
population. This report details the results of the 3-source capture-recapture study for 2006 and 
provides a detailed comparison between the prevalence of problem opiate users in 2001 and in 2006.
It is anticipated that the results will inform national and regional planning for service provision
2 Kelly, A. , Carvalho, M, Teljeur, C. (2003) Prevalence of Opiate Use in Ireland 2000 – 2001: A 3-Source Capture Recapture Study. 
National Advisory Committee on Drugs, Stationery Office, Dublin.
Background
The main parameters of the study, as determined by the National Advisory Committee on Drugs, 
specified that three data sources were to be employed in the study, namely:
i) the Central (methadone)Treatment List (CTL),
ii) the relevant national Garda data on known opiate users and
iii) the Hospital In-Patient Enquiry Scheme (HIPE).
The HIPE data does not include emergency department attendees who are not admitted to hospital.
The Committee requested valid estimates of the prevalence of opiate use in the national population 
for the year 2006.
The advice of the Data Protection Commissioner had been sought and received in preparation for the 
earlier capture-recapture study3 in relation to accessing relevant details from the three sources in 
order to be able to reliably identify individuals appearing in a single source or in more than one 
source. For the purpose of the present study, the Data Protection Commissioner was again contacted 
and it was confirmed that the advice previously received still applied. Individual confidentiality is 
guaranteed and is safeguarded in the study and in the reporting of findings.
Permission was sought and granted to access the Central (methadone) Treatment List and the Garda 
data.
In relation to the hospital data (HIPE), 44 of the 56 acute hospitals throughout the country held 
relevant data on attendances by individual patients with a diagnosis of harmful or dependent opiate 
use. Forty four hospital managers were contacted requesting their co-operation and informing them 
that ethical approval was being sought from the relevant hospital or regional Ethics Committee. On 
receipt of ethical approval, the hospital managers were again contacted and release of the HIPE 
records was requested.
3 Kelly, A. , Carvalho, M, Teljeur, C. (2003) Prevalence of Opiate Use in Ireland 2000 – 2001: A 3-Source Capture Recapture Study. 
National Advisory Committee on Drugs, Stationery Office, Dublin.
Data
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Capture-recapture
A 3-source capture-recapture study determines a prevalence estimate based on identifying 
individuals who appear in one, two or all three datasets (usually referred to as lists in this context) 
within a given year. It may be helpful to visualise this in terms of the figure below (Figure. 1). It is 
evident that individuals may be found in common between any pair of sources as represented in the 
figure by:
T ∩4 H (individuals common to both the Treatment List and HIPE list),
T ∩ G (individuals common to both the Treatment List and Garda list),
H ∩ G (individuals common to both the HIPE and Garda list)
and individuals found in all three lists are represented by:
T ∩ H ∩ G (individuals common to the Treatment list, the HIPE list and the Garda list).
The remaining individuals are unique to each source, i.e. they appear only in one or other of the lists 
as:
T (appearing only in the Treatment list),
H (appearing only in the HIPE list) and
G (appearing only in the Garda list).
Treatment list HIPE
Garda data
HT
G
T ∩ G
T ∩ H
H ∩ G
T ∩ H ∩ G
Figure 1: Illustration of both overlap and non-overlap of individuals common and unique, respectively, to the three 
data sources.
4  The  ∩ symbol is shorthand for intersection or overlap of subjects between the two sources
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Method
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When three sources are used seven numbers are needed in all for the models as displayed in Figure 
1. These are the three numbers of individuals common to any pair of data lists, one number common 
to all three data lists and the three numbers of individuals who are unique to a specific list. These 
numbers are analysed employing a statistical technique suited to capture-recapture modelling and 
known as Log-linear modelling. A model is selected from a variety of candidate models and this 
provides an estimate of the total number (N) of individuals in our population of opiate users - this is 
the prevalence estimate. The fitted model also allows for the computation of a confidence interval 
(conventionally set to 95%) associated with the prevalence estimate to give a range of values within 
which there is 95% assurance that the true prevalence value lies.
Crucial to the success of the modelling exercise is the correct ascertainment of the seven numbers 
referred to above. In order to determine these, it is important to have a reasonably unambiguous 
person identifier in the three data sets. In principle, it is believed that a person’s initials, full date of 
birth and sex suffice to provide a reliable match. In practice, it must be recognised that data 
recording practices can and do give rise to errors in entering any or all of these details in routinely 
collected data intended for administrative or surveillance purposes.
Matching
The records from all three databases were cleaned – this entailed checking dates of birth and person 
initials for any obvious errors and ensuring county of residence was spelled correctly. Once cleaned, 
duplicates between and within sources were removed and the data were put into a common format 
with the following fields:
1. Sex
2. Day of birth
3. Month of birth
4. Year of birth
5. County of residence
6. Forename initial
7. Surname initial(s)
The next step was to define the conditions for two records to be matched. For two records to be 
considered an exact match all seven elements had to match. For two records to be considered an 
inexact or fuzzy match there could be one element of the seven that did not match exactly. Based on 
our research, for the day, month and year of birth fields one of the values could be either ±1 or ±10 
to be counted as a fuzzy match.
For each record the exact and fuzzy matches were determined and recorded. Determining the list of 
individuals for analysis purposes was achieved in three phases. The first phase was to fix the exact 
matches as these were known with certainty. The second phase was to fix records with no exact or 
fuzzy matches as these were also known with certainty. The final phase was to allocate fuzzy matches.
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The output from this exercise was a list of individuals, each with gender, date of birth, county of 
residence and the databases they appear in recorded. The listing was then used to produce the 
summary statistics of counts by age, sex and area of residence appearing in each source and the 
overlaps between the sources.
Figure 2 and Table 2 present the results of this exercise by data source. The circles are proportional 
to the number of opiate users. The three sources of data indicated that there were 11,807 opiate 
users aged 15-64 years known to services in Ireland in 2006. The data analysis excludes the 116 
people who had no fixed abode, the vast majority of whom were in treatment.
Count 
(2006)
7,689
504
1,948
338
1,216
22
90
Source
T
H
G
T ∩ H
T ∩ G
H ∩ G
T ∩ H ∩ G
H
T
G
2006
Figure 2: Venn diagram illustrating the distribution of the numbers (11,807) of known opiate users aged 15-64 years in 
Ireland by source, 2006
Following data cleaning and matching across the three sources, the unique numbers of individuals 
by source for the Dublin region and the Rest of Ireland were determined. The vast majority of cases 
were on the treatment list and lived in Dublin. Table 2 presents a breakdown of the numbers.
Table 2: Numbers of known opiate users aged 15-64 years by data source and place of residence, 2006
Source Ireland
Number
Dublin Rest of Ireland
T 7,689 6,702 987
H 504 415 89
G 1,948 956 992
T ∩ H 338 320 18
T ∩ G 1,216 957 259
H ∩ G 22 12 10
T ∩ H ∩ G 90 80 10
Total number of 
known opiate users
11,807 9,442* 2,365
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Technical limitations of the Capture-Recapture Method
In contrast to our analyses of the data for 2000/01, difficulties arose in the calculation - via Log 
Linear statistical models – of the prevalence estimates in 2006. These difficulties arose for three 
distinct reasons:
1. The first requires that the population in question (opiate users) forms a closed population for the 
period under study (calendar year 2006). This was certainly not the case in 2006, with a major 
expansion of the places available on the national methadone treatment programme (both inside 
and outside of Dublin) between 2001 and 2006 and the substantial number of new entrants (during 
2006) to treatment. There was also a considerable increase in Garda activity outside of Dublin.
2. The second condition assumes “equal catchability” across the three sources, that is, that all 
individuals have an equal opportunity to be captured by each source. This is also affected by the 
expansion of the national methadone treatment programme and the increased level of Garda 
activity. As individuals become stable following a period on methadone treatment, they are less 
likely to appear on the Garda list. Similarly, when there is increased Garda activity, individuals 
coming to the attention of the Garda are less likely to present for treatment – at least initially. 
This requirement of “equal catchability” is managed to a degree using 3-source capture-recapture 
so it is less problematic in practice.
3. Where there is proportionally poorer overlap between sources (in some instances with zero 
overlap) in 2006 as compared to 2001, we find that estimates generally have lower precision – 
especially for the small sub-groups outside Dublin. Additionally, reduced overlap and increased 
numbers within sources result in higher prevalence estimates.
The consequences of violations of any of these conditions will tend to result in inflated national 
prevalence estimates though the over estimate for outside Dublin is thought to be proportionally 
larger. Alternative approaches (to log-linear models) are available and have been implemented in 
this study, however, similar issues arise with similar consequences for estimates.
The socially desirable expansion in the places available on the national methadone treatment 
programme between 2001 and 2006, has introduced, as a side effect, technical complications in the 
estimation of the hidden opiate user population via capture-recapture methods. This will have less 
effect on the estimate for Dublin. However, the extent to which the estimates are inflated is 
unknown.
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Data - A Comparative Analysis by Source
Distribution by Source
A comparative analysis of the demographic characteristics across the data sets is of particular 
interest in highlighting similarities and differences by data source. Table 3 presents the numbers  
of unique individuals across the three sources.
Table 3: Numbers of known opiate users aged 15-64 years within and between data sources in Ireland, 2006
Numbers within and between sources
Source Number (%) Treatment Garda HIPE
T 7,689 (65.1) 7,689
H 504 (4.3) 504
G 1,948 (16.5) 1,948
T ∩ H 338 (2.9) 338 338
T ∩ G 1,216 (10.3) 1,216 1,216
H ∩ G 22 (0.2) 22 22
T ∩ H ∩ G 90 (0.8) 90 90 90
Total 11,807 (100) 9,333 3,276 954
Distribution by Age Band and Sex
There were 11,807 individual opiate users aged 15-64 years identified in the three sources (Table 4). 
Fifty six per cent were aged 25-34 years. Almost three quarters of the opiate users were male. Female 
opiate users tended to be younger.
Table 4: Number (%) of known opiate users in Ireland, by age and sex, 2006
Number (%)
Sex 15-24 25-34 35-64 Total
Female 562 (29) 2,085 (31) 716 (22) 3,363 (28)
Male 1,359 (71) 4,537 (69) 2,548 (78) 8,444 (72)
Total  1,921 (100) 6,622 (100) 3,264 (100) 11,807 (100)
When the data were examined by source, the highest proportion of opiate users were aged 25-34 
years (Table 5). The individuals in the Garda data were younger than the people in treatment or 
hospital; the latter were broadly similar. There was a higher proportion of males in the Garda data 
than the proportion of males in the other two data sources. In HIPE, the male to female ratio was 
broadly similar. The distribution of gender in the Central (methadone) Treatment List fell somewhere 
between that for HIPE and Garda.
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Table 5: Percentage of known opiate users aged 15-64 years in Ireland, by age, sex and data source, 2006
% within Source 
Age band Average% Garda HIPE Treatment
15-24 16.3 33.0 14.3 10.5
25-34 56.1 51.0 55.3 59.1
35-64 27.6 16.0 30.4 30.4
Sex
Female 28.5 15.8 48.1 29.7
Male 71.5 84.2 51.9 70.3
The mean or average age of those known only to the Garda was significantly lower than those 
appearing uniquely in either the treatment or HIPE lists for both males and females (Table 6). 
Females tended to be younger than males in each source with the exception of females known 
uniquely to the Garda. Considering the overlap between any pair of sources, again it was seen that 
those intersections in which the Garda list was one of the pair the mean age tended to be lower on 
average. The mean age for those persons appearing in the three-way intersection (males: 30.4; 
females: 28.4) was midway between the mean ages from each of the three sources.
Table 6: Mean age with standard deviation of opiate users aged 15-64 years in Ireland, by source and sex, 2006
Males Females
Source Number
Mean
Age Std Dev Number
Mean
Age Std Dev
G 1,664 27.1 7.3 284 26.6 7.2
H 197 34.3 9.6 307 29.7 7.6
T 5,283 33.2 7.3 2,406 31.0 6.5
Intersections
T ∩ H 19 29.9 5.2 3 24.7 1.5
T ∩ G 207 34.4 7.5 131 31.5 6.4
H ∩ G 1,002 29.9 5.9 214 28.0 5.6
T ∩ H ∩ G 72 30.4 5.5 18 28.4 5.5
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Table 7 presents percentages by the person’s sex within source for each of the three age groups for 
2006 and these are displayed visually in Figure 3. The percentage of males was higher in each 
category with two exceptions, namely, HIPE for the two age groups 15-24 and 24-34.
Table 7: Percentages of opiate users aged 15-64 years in Ireland, by sex ,age and source
Percentage
Sex Age 15-24 years Age 25-34 years Age 35-64 years
G H T G H T G H T
Female 17.9 63.2 36.7 15.8 54.2 32.3 11.7 30.0 22.1
Male 82.1 36.8 63.3 84.2 45.8 67.7 88.3 70.0 77.9
60-64
55-59
50-54
45-49
40-44
35-39
30-34
25-29
20-24
15-19
2,000
Males Females
1,500 1,000 500 0 500 1,000 1,500 2,000
60-64
55-59
50-54
45-49
40-44
35-39
30-34
25-29
20-24
15-19
60-64
55-59
50-54
45-49
40-44
35-39
30-34
25-29
20-24
15-19
Treatment
Garda
Hipe
Figure 3: A scaled population pyramid showing the age distribution for male and female opiate users aged 15-64 years 
in Ireland, by source, 2006.
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1) Ireland
Table 8 presents a summary of the prevalence estimates of opiate users with 95% confidence 
intervals by sex and age in Ireland in 2006. Estimates are based on a summation of the Dublin and 
rest of Ireland estimates within each age and/or sex combination. Figure 4 presents a visual 
representation of these estimates (with 95% Confidence Intervals). The unique number of individuals 
identified across the three sources was 11,807. This indicates that 57% of opiate users aged 15-64 
years were known to the three sources in 2006.
Table 8: Prevalence estimates of opiate users with 95% confidence intervals for males and females in Ireland, by age, 2006
Year Sex Age Group
Prevalence
Estimates
Lower 
Bound*
Upper
Bound*
Rate/
1000 
population
2006 Males 15-24 3,150 2,709 3,739 9.8
25-34 7,238 6,799 7,769 19.7
35-64 4,399 3,969 4,977 5.6
Females 15-24 1,159 933 1,525 3.7
25-34 3,298 2,511 3,411 9.3
35-64 1,546 1,215 2,155 2.0
Total Male+Female 15-64 20,790 18,136 23,576 7.2
* Lower Bound = lower 95% Confidence Interval; Upper Bound = upper 95% Confidence Interval
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
5,000
5,500
6,000
6,500
7,000
7,500
8,000
F 35-64F 25-34F 15-24M 35-64M 25-34M 15-24
Estimates 2006
Figure 4: Prevalence estimates of opiate users with 95% confidence intervals for males and females in Ireland, by age, 2006.
Results
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2) Dublin
Results of the 3-source capture-recapture models for Dublin for 2006 stratified by age and sex are 
presented in Table 9. Figure 5 presents a visual representation of these estimates (with 95% 
Confidence Intervals). The unique number of individuals living in Dublin identified across the three 
sources was 9,442. This indicates that 63% of opiate users aged 15-64 years were known to the three 
sources in 2006.
Table 9: Prevalence estimates of opiate users with 95% confidence intervals for males and females in Dublin, by age, 2006
Year Sex Age Group
Prevalence
Estimates
Lower 
Bound*
Upper
Bound*
Rate/
1000 
population
2006 Males 15-24 1,892 1,661 2,188 19.9
25-34 5,172 4,967 5,407 43.0
35-64 3,331 3,113 3,599 16.3
Females 15-24 701 586 881 7.2
25-34 2,605 2,395 2,894 21.9
35-64 1,203 1,015 1,481 5.7
Total Male+Female 15-64 14,904 13,737 16,450 17.6
* Lower Bound = lower 95% Confidence Interval; Upper Bound = upper 95% Confidence Interval
0
500
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Figure 5: Prevalence estimates of opiate users with 95% confidence intervals for males and females in Dublin, by age, 2006
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Figure 6 presents visually the number of known and hidden opiate users in Dublin and the rest of 
Ireland in 2006. The circles are proportional to the number of opiate users. The numbers, 5,462 and 
3,521, represents the estimates of the hidden population of opiate users for Dublin and the Rest of 
Ireland, respectively
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Figure 6: Venn diagrams illustrating the distribution of numbers of known and 
hidden opiate users in Dublin and the Rest of Ireland, 2006
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3) Rest of Ireland (excluding Dublin)
Results of the 3-source capture-recapture models for the Rest of Ireland (excluding Dublin) for 2006 
stratified by age and sex are presented in Table 10. Figure 7 presents a visual representation  
of these estimates (with 95% Confidence Intervals). The unique number of individuals living outside 
Dublin identified across the three sources was 2,365. This indicates that 40% of opiate users aged 
15-64 years were known to the three sources in 2006.
Table 10: Prevalence estimates of opiate users with 95% confidence intervals for males and females outside Dublin, 
by age, 2006
Year Sex Age Group
Prevalence
Estimates
Lower 
Bound*
Upper
Bound*
Rate/
1000 
population
2006 Males 15-24 1,258 1,048 1,551 5.6
25-34 2,066 1,832 2,362 8.4
35-64 1,068 856 1,378 1.8
Females 15-24 458 347 644 2.1
25-34 693 116 517 2.9
35-64 343 200 674 0.6
Total Male+Female 15-64 5,886 4,399 7,126 2.9
* Lower Bound = lower 95% Confidence Interval; Upper Bound = upper 95% Confidence Interval
Estimates 2006
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Figure 7: Prevalence estimates of opiate users with 95% confidence intervals for males and females outside Dublin, 
by age, 2006
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Percentage of Known Numbers in Treatment by Age, Sex and Region
The percentages of the unique and known individuals in treatment across the three data sources are 
presented in Table 11 for each region.
Table 11: Percentages of known opiate users receiving methadone treatment, by age, sex and place of residence,2006
Sex Age band % of unique or known numbers in Treatment
Dublin Rest of Ireland Ireland
Male 15-24 55 31 42
25-34 85 57 82
35-64 91 63 87
Female 15-24 70 52 64
25-34 87 72 85
35-64 91 67 88
The lowest percentage in treatment was for young males outside Dublin (31% - males 15-24 years). 
The percentages were consistently lower than those for Dublin. This reflected the more recent spread 
of opiate use outside Dublin and the ensuing but more recent development of (and continuing need 
to expand) methadone treatment services outside of Dublin. Additionally, the percentages in 
treatment increased with age. Within each age group, females tended to have higher proportions in 
treatment compared to males, particularly so for the younger age bands. In Dublin, the numbers in 
treatment were just over four times higher than those known to the Gardaí. The ratio of treatment to 
Garda numbers outside Dublin is close to 1:1. This ratio of those in treatment and those known to  
the Garda outside Dublin will evolve in time to resemble the situation in Dublin as the methadone 
treatment services expand in the coming years. Nationally, of those who were in treatment prior  
to 2006, only 10% were also known to the Gardaí. By comparison, for those entering methadone 
treatment for the first time in 2006, about 20% were known to the Gardaí.
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4) National and Regional Comparisons between 2001 and 2006
Table 12: Numbers of opiate users aged 15-64 years in Ireland unique to each source and overlaps between sources, 
2001 and 2006.
Source 2001 2006
Number
T 4,525 7,689
H 405 504
G 1,896 1,948
T ∩ H 386 338
T ∩ G 1,712 1,216
H ∩ G 45 22
T ∩ H ∩ G 204 90
Total 9,173 11,807
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Figure 8: Venn diagrams illustrating the distribution of numbers of known and hidden opiate users in Ireland, 2001 and 
2006
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Table 12 and Figure 8 depict the national numbers for each source and source intersection for both 
2001 and 2006. The number in treatment was significantly higher in 2006 compared to 2001. The 
intersection or overlap between sources tended to be smaller in 2006 than in 2001. The most marked 
change in overlaps was in terms of the numbers in methadone treatment, for example:
• The unique number in T has risen by 3,164
• The unique number in H has risen by 99
• The unique number in G has risen by a small amount of 52
• The overlap between Treatment and HIPE (T ∩ H) has decreased by 48
• The overlap between Treatment and Garda (T ∩ G) has decreased by 496
• The overlap between HIPE and Garda (H ∩ G) has more than halved.
• The three-way overlap has dropped very substantially by 114
Overall, the unique numbers increased for all sources (in particular for T) while the individual 
overlaps have actually decreased. A reduction in any overlap has the effect of increasing the 
prevalence estimate. The increase in numbers coupled with the decrease in overlap in 2006 led to  
an increase in the estimate of the unknown or hidden population by age and gender. The results  
are summarised for males and females separately in Tables 13 and 14, respectively. Males and 
females combined are presented in Table 15.
Table 13: Prevalence estimates of male opiate users, by age and place of residence, 2001 and 2006
Prevalence estimates Rate / 1000 population
Region Age Band 2001 2006 2001 2006
Dublin 15-24 2,735 1,892 29.3 19.9
25-34 3,740 5,172 36.3 43.0
35-64 1,803 3,331 9.9 16.3
Rest of 
Ireland
15-24 1,258 5.6
25-34 2,066 8.4
35-64 1,068 1.8
15-64 1,688 4,392 1.8 4.2
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Table 14: Prevalence estimates of female opiate users, by age and place of residence, 2001 and 2006
Prevalence estimates Rate / 1000 population
Region Age Band 2001 2006 2001 2006
Dublin 15-24 1,766 701 18.7 7.2
25-34 1,784 2,605 16.2 21.9
35-64 628 1,203 3.2 5.7
Rest of 
Ireland
15-24 458 2.1
25-34 693 2.9
35-64 343 0.6
15-64 537 1,494 0.6 1.5
Table 15: Prevalence estimates of opiate users aged 15-64 years, by place of residence, 2001 and 2006.
Region Sex/Age Band Prevalence estimates Rate / 1000 population
2001 2006 2001 2006
Dublin
Male+Female 
15-64
12,456 14,904 15.9 17.6
Rest of 
Ireland
Male+Female 
15-64
2,225 5,886 1.2 2.9
Ireland
Male+Female 
15-64
14,681 20,790 5.6 7.2
The only group to experience a reduction in prevalence is the 15-24 age band with a drop of 31% for 
males in Dublin and 60% for females in Dublin (Tables 13 & 14).
Within Dublin the cohort effect is very noticeable, with individuals ageing by 5 years since the 2001 
study and (for the most part, staying in treatment) so the “bulge” in prevalence estimates shifted to 
the middle age band in 2006. This is not evident for Ireland as a whole, due to the large increase in 
numbers identified outside Dublin.
For males and females combined and across all age bands, both prevalence estimates and 
population rates have risen between 2001 and 2006. Inter alia, this was inevitable given the 
substantially increased numbers on methadone treatment over the five years.
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Prevalence Estimates
The 3-source capture-recapture results for Ireland suggest a figure of 20,790 (95% CI: 18,136 to 23,576). 
This would imply a rise of just under 6,000 between 2001 and 2006. However, we have already 
expressed concerns that the 2006 estimate is likely to be somewhat inflated due to technical reasons.
In interpreting this rise, consideration must also be given to the substantial increase in the number 
of individuals in treatment between 2001 and 2006 (rising from 6,827 to 9,435). The population rate 
for 2001 was 5.6 per 1,000 persons aged 15-64 and for 2006 it was 7.2 per 1,000 persons aged 15-64.
The estimates for Dublin were 14,904 (95% CI: 13,737 to 16,450) for 2006 giving a population rate  
of 17.6. The corresponding figure for 2001 was 12,456 (95% CI: 11,519 to 13,711) with a population 
rate of 15.9 per 1,000. Note that the 95% confidence intervals almost overlap so the difference in 
estimates was just statistically significant.
The prevalence for the Rest of Ireland (excluding Dublin) was estimated as 5,886 (95% CI: 4,399 to 
7,126) in 2006. This indicates that the estimate more than doubled when compared to 2001 (2,225; 
95% CI: 1,934 to 2,625). The corresponding rate per 1,000 population for 2006 is 2.9 as compared to 
1.2 for 2001.
Concluding Remarks
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